Table:
begin	end	state
1	5	non-cytoplasmic
6	21	transmembrane
22	31	cytoplasmic
32	51	transmembrane
52	69	non-cytoplasmic
70	92	transmembrane
93	103	cytoplasmic
104	127	transmembrane
128	183	non-cytoplasmic
184	203	transmembrane
204	222	cytoplasmic
223	243	transmembrane
244	257	non-cytoplasmic
258	282	transmembrane
283	293	cytoplasmic
294	315	transmembrane
316	334	non-cytoplasmic
335	357	transmembrane
358	368	cytoplasmic
369	387	transmembrane
388	392	non-cytoplasmic
393	414	transmembrane
415	463	cytoplasmic

Input:
>WP_111605625.1 NCBI__GCF_003259225.1:WP_111605625.1
MLYPILNLAVFALLIALLFKLQKAKKTLSTQVFTGLGLGVAFGAALQFIYGVDSATNSET
LEYVNIVGYGYVSLLKMIIMPLILVSIIGAIVKVKDTGSLGKMSGGIIGILLATTAVSAL
IGVFVSNLFGLSAEGIVQGAREMARGAALETSLEGLASVSFADMITSFFPGNPFADLAGS
RPTSTIAVVIFAAFVGIAGVTVARKEPELGASFERFVDVAQSIVRTLVRMVLSLTPYGIL
ALMTKVVAGSNVSDILTLLNFVVASYVGLALILVMHLCLLAFNGISPLRYLKKVLPVLLF
AFTSRSSAGTIPLNIDTQVKRLGNGEGESNFSASFGATMGQNGCAGLYPAMLAVMIAPTI
GINPLDPSFIISLIAIVTISSFGIAGIGGGATFAALIVLSALDMPVALAGLLISIEPLID
MGRTAVNVNGAMTAGTITSKWLGHSDAGVFARDEEPELELKNS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server